Skip to main content
Top
Published in: BMC Cancer 1/2024

Open Access 01-12-2024 | Breast Cancer | Research

Validation of primary and outcome data quality in a Swedish population-based breast cancer quality registry

Authors: Sofia Palmér, Carl Blomqvist, Marit Holmqvist, Henrik Lindman, Mats Lambe, Johan Ahlgren

Published in: BMC Cancer | Issue 1/2024

Login to get access

Abstract

Background

Population-based cancer quality registries are of great importance for the improvement of cancer care. However, little is known about the quality of recurrence data in cancer quality registries. The aim of this study was to evaluate data quality in the regional Breast Cancer Quality Registry of Central Sweden, with emphasis on the validity of recorded information on recurrence.

Methods

Validation by re-abstraction was performed on a random sample of 800 women with primary invasive breast cancer stage I-III diagnosed between 1993 and 2010, of which 400 had at least one registered recurrence and 400 had no registered recurrence. Registry data were compared with data from medical records. Exact agreement, correlation and kappa values, sensitivity and specificity were calculated.

Results

Seven hundred forty-seven women (93%) were available for analysis. Exact agreement was high for diagnostics, tumor characteristics, surgery, and adjuvant oncological treatment (90% or more for most variables). The registry’s sensitivity was low for regional recurrence (47%), but higher for local and distant recurrence (80% and 75%), whereas specificity was overall high (≥ 95%). Combining all recurrence categories irrespective of localization improved sensitivity to 90% with a specificity of 91%. In 87% of women, the date of first recurrence according to medical records fell within ± 90 days of the date recorded in the registry.

Conclusions

While the quality of data in the regional Breast Cancer Quality Registry was generally high, data accuracy on recurrences was lower. The overall precision of identifying any recurrence, irrespective of localization, was high. However, the accuracy of classification of recurrences (local, regional or distant) was lower, with evidence of underreporting for each of the recurrence categories. Given the importance of recurrence-related outcomes in the assessment of quality of care, efforts should be made to improve the reporting of recurrences.
Appendix
Available only for authorised users
Literature
2.
go back to reference Armstrong BK. The role of the cancer registry in cancer control. Cancer Causes Control. 1992;3:569–79.CrossRefPubMed Armstrong BK. The role of the cancer registry in cancer control. Cancer Causes Control. 1992;3:569–79.CrossRefPubMed
3.
go back to reference Polissar L, Feigl P, Lane WW, Glaefke G, Dahlberg S. Accuracy of basic cancer patient data: results from an extensive recoding survey. J Natl Cancer Inst. 1984;72:1007–14.PubMed Polissar L, Feigl P, Lane WW, Glaefke G, Dahlberg S. Accuracy of basic cancer patient data: results from an extensive recoding survey. J Natl Cancer Inst. 1984;72:1007–14.PubMed
4.
go back to reference Liu WL, Kasl S, Flannery JT, Lindo A, Dubrow R. The accuracy of prostate cancer staging in a population-based tumor registry and its impact on the black-white stage difference (Connecticut, United States). Cancer Causes Control. 1995;6:425–30.CrossRefPubMed Liu WL, Kasl S, Flannery JT, Lindo A, Dubrow R. The accuracy of prostate cancer staging in a population-based tumor registry and its impact on the black-white stage difference (Connecticut, United States). Cancer Causes Control. 1995;6:425–30.CrossRefPubMed
5.
6.
go back to reference Seddon DJ, Williams EM. Data quality in population-based cancer registration: an assessment of the Merseyside and Cheshire Cancer Registry. Br J Cancer. 1997;76:667–74.CrossRefPubMedPubMedCentral Seddon DJ, Williams EM. Data quality in population-based cancer registration: an assessment of the Merseyside and Cheshire Cancer Registry. Br J Cancer. 1997;76:667–74.CrossRefPubMedPubMedCentral
7.
16.
go back to reference Jensen AR, Storm HH, Moller S, Overgaard J. Validity and representativity in the Danish breast Cancer Cooperative Group–a study on protocol allocation and data validity from one county to a multi-centre database. Acta Oncol. 2003;42:179–85.CrossRefPubMed Jensen AR, Storm HH, Moller S, Overgaard J. Validity and representativity in the Danish breast Cancer Cooperative Group–a study on protocol allocation and data validity from one county to a multi-centre database. Acta Oncol. 2003;42:179–85.CrossRefPubMed
27.
go back to reference Hansen PS, Andersen E, Andersen KW, Mouridsen HT. Quality control of end results in a Danish adjuvant breast cancer multi-center study. Acta Oncol. 1997;36:711–4.CrossRefPubMed Hansen PS, Andersen E, Andersen KW, Mouridsen HT. Quality control of end results in a Danish adjuvant breast cancer multi-center study. Acta Oncol. 1997;36:711–4.CrossRefPubMed
Metadata
Title
Validation of primary and outcome data quality in a Swedish population-based breast cancer quality registry
Authors
Sofia Palmér
Carl Blomqvist
Marit Holmqvist
Henrik Lindman
Mats Lambe
Johan Ahlgren
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-024-12073-4

Other articles of this Issue 1/2024

BMC Cancer 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine